Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 264

1.

Risk of stroke and intracranial hemorrhage in 9727 Chinese with atrial fibrillation in Hong Kong.

Siu CW, Lip GY, Lam KF, Tse HF.

Heart Rhythm. 2014 Aug;11(8):1401-8. doi: 10.1016/j.hrthm.2014.04.021. Epub 2014 Apr 15.

PMID:
24747420
2.

Efficacy and safety of dabigatran, rivaroxaban, and warfarin for stroke prevention in Chinese patients with atrial fibrillation: the Hong Kong Atrial Fibrillation Project.

Li WH, Huang D, Chiang CE, Lau CP, Tse HF, Chan EW, Wong ICK, Lip GYH, Chan PH, Siu CW.

Clin Cardiol. 2017 Apr;40(4):222-229. doi: 10.1002/clc.22649. Epub 2016 Nov 28.

3.

Incidence and prediction of ischemic stroke among atrial fibrillation patients with end-stage renal disease requiring dialysis.

Chao TF, Liu CJ, Wang KL, Lin YJ, Chang SL, Lo LW, Hu YF, Tuan TC, Chung FP, Liao JN, Chen TJ, Lip GY, Chen SA.

Heart Rhythm. 2014 Oct;11(10):1752-9. doi: 10.1016/j.hrthm.2014.06.021. Epub 2014 Jun 18.

PMID:
24952148
4.

Stroke prevention using dabigatran in elderly Chinese patients with atrial fibrillation.

Chan PH, Huang D, Hai JJ, Li WH, Yin LX, Chan EW, Wong IC, Lau CP, Chiang CE, Zhu J, Tse HF, Siu CW.

Heart Rhythm. 2016 Feb;13(2):366-73. doi: 10.1016/j.hrthm.2015.09.015. Epub 2015 Sep 21.

PMID:
26392326
5.

Net clinical benefit of warfarin therapy in elderly Chinese patients with atrial fibrillation.

Siu CW, Tse HF.

Circ Arrhythm Electrophysiol. 2014 Apr;7(2):300-6. doi: 10.1161/CIRCEP.113.000858. Epub 2014 Mar 7.

6.

The HAS-BLED score has better prediction accuracy for major bleeding than CHADS2 or CHA2DS2-VASc scores in anticoagulated patients with atrial fibrillation.

Roldán V, Marín F, Manzano-Fernández S, Gallego P, Vílchez JA, Valdés M, Vicente V, Lip GY.

J Am Coll Cardiol. 2013 Dec 10;62(23):2199-204. doi: 10.1016/j.jacc.2013.08.1623. Epub 2013 Sep 18.

7.

The net clinical benefit of warfarin anticoagulation in atrial fibrillation.

Singer DE, Chang Y, Fang MC, Borowsky LH, Pomernacki NK, Udaltsova N, Go AS.

Ann Intern Med. 2009 Sep 1;151(5):297-305.

8.

Net clinical benefit of antithrombotic therapy in patients with atrial fibrillation and chronic kidney disease: a nationwide observational cohort study.

Bonde AN, Lip GY, Kamper AL, Hansen PR, Lamberts M, Hommel K, Hansen ML, Gislason GH, Torp-Pedersen C, Olesen JB.

J Am Coll Cardiol. 2014 Dec 16;64(23):2471-82. doi: 10.1016/j.jacc.2014.09.051.

9.

Comparative Performance of ATRIA, CHADS2, and CHA2DS2-VASc Risk Scores Predicting Stroke in Patients With Atrial Fibrillation: Results From a National Primary Care Database.

van den Ham HA, Klungel OH, Singer DE, Leufkens HG, van Staa TP.

J Am Coll Cardiol. 2015 Oct 27;66(17):1851-9. doi: 10.1016/j.jacc.2015.08.033.

10.

A net clinical benefit analysis of warfarin and aspirin on stroke in patients with atrial fibrillation: a nested case-control study.

Azoulay L, Dell'Aniello S, Simon TA, Langleben D, Renoux C, Suissa S.

BMC Cardiovasc Disord. 2012 Jun 26;12:49. doi: 10.1186/1471-2261-12-49.

11.

Validation of a Modified CHA2DS2-VASc Score for Stroke Risk Stratification in Asian Patients With Atrial Fibrillation: A Nationwide Cohort Study.

Chao TF, Lip GY, Liu CJ, Tuan TC, Chen SJ, Wang KL, Lin YJ, Chang SL, Lo LW, Hu YF, Chen TJ, Chiang CE, Chen SA.

Stroke. 2016 Oct;47(10):2462-9. doi: 10.1161/STROKEAHA.116.013880. Epub 2016 Sep 13.

PMID:
27625386
12.

The CHADS2 and CHA 2DS 2-VASc scores predict new occurrence of atrial fibrillation and ischemic stroke.

Zuo ML, Liu S, Chan KH, Lau KK, Chong BH, Lam KF, Chan YH, Lau YF, Lip GY, Lau CP, Tse HF, Siu CW.

J Interv Card Electrophysiol. 2013 Jun;37(1):47-54. doi: 10.1007/s10840-012-9776-0. Epub 2013 Feb 7.

PMID:
23389054
13.

Ischemic stroke and intracranial hemorrhage with aspirin, dabigatran, and warfarin: impact of quality of anticoagulation control.

Ho CW, Ho MH, Chan PH, Hai JJ, Cheung E, Yeung CY, Lau KK, Chan KH, Lau CP, Lip GY, Leung GK, Tse HF, Siu CW.

Stroke. 2015 Jan;46(1):23-30. doi: 10.1161/STROKEAHA.114.006476. Epub 2014 Nov 18.

14.
15.

Roles of the CHADS2 and CHA2DS2-VASc scores in post-myocardial infarction patients: Risk of new occurrence of atrial fibrillation and ischemic stroke.

Lau KK, Chan PH, Yiu KH, Chan YH, Liu S, Chan KH, Yeung CY, Li SW, Tse HF, Siu CW.

Cardiol J. 2014;21(5):474-83. doi: 10.5603/CJ.a2014.0034. Epub 2014 May 20.

PMID:
24846512
16.

Use of Oral Anticoagulants for Stroke Prevention in Patients With Atrial Fibrillation Who Have a History of Intracranial Hemorrhage.

Chao TF, Liu CJ, Liao JN, Wang KL, Lin YJ, Chang SL, Lo LW, Hu YF, Tuan TC, Chung FP, Chen TJ, Lip GY, Chen SA.

Circulation. 2016 Apr 19;133(16):1540-7. doi: 10.1161/CIRCULATIONAHA.115.019794. Epub 2016 Mar 11.

17.

Use of the SAMe-TT2R2 Score to Predict Good Anticoagulation Control with Warfarin in Chinese Patients with Atrial Fibrillation: Relationship to Ischemic Stroke Incidence.

Chan PH, Hai JJ, Chan EW, Li WH, Tse HF, Wong IC, Lip GY, Siu CW.

PLoS One. 2016 Mar 24;11(3):e0150674. doi: 10.1371/journal.pone.0150674. eCollection 2016.

18.

Comparisons of CHADS2 and CHA2DS2-VASc scores for stroke risk stratification in atrial fibrillation: Which scoring system should be used for Asians?

Chao TF, Liu CJ, Tuan TC, Chen SJ, Wang KL, Lin YJ, Chang SL, Lo LW, Hu YF, Chen TJ, Chiang CE, Chen SA.

Heart Rhythm. 2016 Jan;13(1):46-53. doi: 10.1016/j.hrthm.2015.08.017. Epub 2015 Aug 12.

PMID:
26277496
19.

Time Trends of Aspirin and Warfarin Use on Stroke and Bleeding Events in Chinese Patients With New-Onset Atrial Fibrillation.

Guo Y, Wang H, Tian Y, Wang Y, Lip GYH.

Chest. 2015 Jul;148(1):62-72. doi: 10.1378/chest.14-2018.

20.

Supplemental Content

Support Center